
FDA approves another Biogen Alzheimer’s drug
The U.S. Food and Drug Administration has approved a second Alzheimer’s disease drug made by Biogen Inc. with its Japanese partner, Eisai Inc. Click here to view original post
The U.S. Food and Drug Administration has approved a second Alzheimer’s disease drug made by Biogen Inc. with its Japanese partner, Eisai Inc. Click here to view original post
Our Project Delivery team directs, coordinates and manages the technical and operational aspects of projects, securing the successful completion of… Click here to view original post
The successful candidate will be responsible for target discovery and validation efforts, characterization of mechanism of action for gene therapy… Click here to view original post
REPORTS TO: Director Data Management or Designee. Associate Director Data Management position is to direct data management staff to ensure… Click here to view original post
Kick-start design and development of backbone downstream processes CHO protein subunit vaccine antigen for company pipeline projects in early CMC… Click here to view original post
Execute manufacturing operations using disposable technologies, automation, and Manufacturing Execution Systems (MES) to produce mRNA. $30 – $34 an hourFrom… Click here to view original post
Bachelor's degree in life science, biotechnology or engineering is ideal. Minimum of 1 year of experience OR equivalent; experience in… Click here to view original post
Strong technical understanding of the production processes used in the pharmaceutical/biotechnology industry. Provides quality support to site capital projects,…From CSL… Click here to view original post
Maryland-based manufacturer Emergent BioSolutions is kicking off the new year with a multimillion-dollar contract to supply a lotion used in case of chemical attacks. Emergent said on Thursday that it has inked an “indefinite-delivery” and […]
Gene editing biotech Precision BioSciences received positive feedback from FDA for its CAR-T candidate, the biotech announced Friday. The North Carolina biotech said that the federal regulatory agency gave positive Type C feedback on Precision’s […]
Copyright © 2022 Biotech Networks